Entering edit mode
4.4 years ago
cagdas
▴
10
Hi,
I performed a DE miRNAs analyses via GEO2R for https://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE78775. I obtained an upregulation for miR-148a in tumors compared with normal. When I search miR-148a in Pubmed, unfortunately a lot of paper say it is downregulated (in exp., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982598/). Could you help me to interpret the GEO2R results or re-perform the analyses according to your codes / softwares, please?
Thanks
May sound trivial but did you confirm the comparison order of the classes/groups in your analysis?
Yes, I confirmed it, no problem...
There is something strange happening. You may have to contact the authors:
Kevin thank you for your detailed reply.
Also following paper had found a downregulation. What can be the problem Kevin? https://www.nature.com/articles/s10038-020-0746-6
Not for me to follow-up - I would clarify with the authors. This miR is clearly up-regulated in tumor, judging by the box-and-whiskers plot (above). Perhaps the authors are segregating by
sex
|gender
, though (?)They may have made a mistake with their metadata - not sure.
Even in their published work (Paper), they stated that this miRNA is down-regulated in GC patients. I believe they mixed the samples between tumor and normal when uploaded to GEO . As the others mentioned, best to check with author.